InvestorsHub Logo
Followers 64
Posts 2029
Boards Moderated 0
Alias Born 10/31/2017

Re: None

Monday, 06/28/2021 8:31:15 AM

Monday, June 28, 2021 8:31:15 AM

Post# of 303
CRISPR/Cas9 company Intellia and Regeneron report first in-human gene editing results in 6 ATTR patients showing positive safety and efficacy data. I had no idea that they were this far along. Pretty impressive.

https://ir.intelliatx.com/news-releases/news-release-details/intellia-and-regeneron-announce-landmark-clinical-data-showing
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent DTIL News